ISG15 and breast carcinoma: Moreover, an increase in the ubiquitination levels in breast cancer cells is promoted by the reduction of ISG15 or UBCH8 (ubiquitin‐conjugating enzyme H8, an ISG15 conjugating E2 enzyme), suggesting that ISGylation avoids protein ubiquitination and confers stability.17